Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab plus clarithromycin for moderate to severe hidradenitis suppurativa
NL-OMON23669Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in hidradenitis suppurativa (HS) comparing Clarithromycin + placebo with Clarithromycin + adalimumab (2 arms). Primary endpoint: Modified Sartorius HS score. Planned start Jul 2009; status: not yet recruiting.
02
Drugs
adalimumabclarithromycin
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NL-OMON23669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23669.